Diseases of the Conjunctiva

On this page

👁️ Conjunctival Fortress: The Eye's First Line of Defense

The conjunctiva may seem like a simple transparent membrane, but it orchestrates a sophisticated defense system that reveals systemic disease, guides antibiotic stewardship, and determines whether a red eye is benign or vision-threatening. You'll master the vascular patterns that distinguish viral from bacterial conjunctivitis, decode morphological signatures like follicles and papillae, and build decision algorithms that connect ocular findings to systemic conditions from Kawasaki disease to pemphigoid. By integrating anatomy, pattern recognition, and therapeutic precision, you'll transform conjunctival examination from routine screening into diagnostic command.

Conjunctival Architecture: The Protective Blueprint

The conjunctival system operates through three distinct anatomical zones, each with specialized functions and unique pathological vulnerabilities:

  • Palpebral Conjunctiva (2-3mm thick)

    • Firmly adherent to tarsal plates
    • Rich vascular supply with 40-50 vessels/mm²
    • Primary site for cicatricial changes
      • Trachoma scarring patterns
      • Chemical burn sequelae
      • Autoimmune cicatrization
  • Fornix Conjunctiva (loose, mobile)

    • Maximum 8-10mm depth in superior fornix
    • Critical for tear pooling and distribution
    • Vulnerable to shortening in cicatricial diseases
      • >2mm fornix loss indicates severe disease
      • Symblepharon formation risk zone
  • Bulbar Conjunctiva (transparent, mobile)

    • Overlies episclera with loose attachment
    • 0.3-0.5mm thickness allows vessel visualization
    • Primary site for degenerative changes
      • Pterygium development zone
      • Pinguecula formation area

📌 Remember: FAST Conjunctival Zones - Fornix (deepest), Adherent (palpebral), Sliding (bulbar), Tear distribution (all zones coordinate tear film stability)

Cellular Defense Network: The Microscopic Army

The conjunctival epithelium maintains a sophisticated cellular hierarchy that responds to pathological challenges with predictable patterns:

Cell TypeDensity (/mm²)Primary FunctionDisease ResponseClinical Significance
Epithelial Cells2,500-3,000Barrier functionHyperplasia in chronic inflammationPapillary formation
Goblet Cells300-500Mucin productionDecreased in dry eye (<200/mm²)Tear film instability
Langerhans Cells50-80Antigen presentationIncreased in allergic diseaseHypersensitivity reactions
Plasma Cells20-40IgA productionMassive increase in trachomaLocal immunity
Mast Cells10-20Mediator releaseDegranulation in allergyImmediate hypersensitivity

The conjunctival immune system operates through coordinated responses that create characteristic clinical patterns. Understanding these cellular interactions predicts disease progression and treatment responses across all conjunctival pathologies.

💡 Master This: Every conjunctival disease follows predictable cellular response patterns - acute inflammation triggers neutrophil infiltration within 2-4 hours, chronic inflammation develops lymphocytic infiltrates over 7-14 days, and cicatricial changes require >3 months of sustained inflammation.

Connect this foundational understanding through vascular and neural networks to understand how conjunctival diseases spread and manifest systemically.

👁️ Conjunctival Fortress: The Eye's First Line of Defense

🌊 Vascular Networks: The Conjunctival Circulation Command

Triple Vascular Architecture: The Blood Supply Matrix

The conjunctival vascular system organizes into three functionally distinct networks, each responding differently to pathological stimuli:

Loading diagram…
  • Superficial Conjunctival Vessels

    • Arise from palpebral arteries
    • 100-150μm diameter in health
    • Dilate to 300-400μm in acute inflammation
      • Mobile with conjunctival movement
      • Blanch with topical vasoconstrictors
      • Primary responders in allergic reactions
  • Deep Conjunctival Network

    • Connects to anterior ciliary circulation
    • 50-80μm baseline diameter
    • Fixed position, non-mobile
      • Resistant to vasoconstrictor drops
      • Indicates deeper ocular inflammation
      • >2x dilation suggests scleritis risk
  • Episcleral Vascular Plexus

    • 200-250μm vessel diameter
    • Radial pattern around limbus
    • Critical for corneal nutrition
      • 15-20% of corneal oxygen supply
      • Compromised in cicatricial diseases
      • Restoration indicates healing progress

📌 Remember: MOBILE Vessel Assessment - Mobile vessels (superficial), Obvious with movement, Blanch with drops, Immobile vessels (deep), Limbal pattern (episcleral), Evaluate inflammation depth

Lymphatic Drainage: The Immune Highway System

The conjunctival lymphatic system creates predictable drainage patterns that determine infection spread and immune responses:

Drainage ZoneLymph Node TargetDrainage TimeClinical SignificancePathology Patterns
Medial ConjunctivaSubmandibular nodes2-4 hoursDacryocystitis spreadPreseptal cellulitis risk
Lateral ConjunctivaPreauricular nodes1-3 hoursViral conjunctivitis90% EKC cases
Superior ConjunctivaDeep cervical chain4-6 hoursSystemic involvementParinaud syndrome
Inferior ConjunctivaSubmandibular nodes3-5 hoursBacterial seedingOrbital cellulitis risk
Limbal RegionMultiple pathways1-2 hoursRapid systemic accessSevere allergic reactions

The lymphatic drainage patterns explain why certain conjunctival infections become systemic while others remain localized. Understanding these pathways guides antibiotic selection and predicts complications.

💡 Master This: Conjunctival lymphatic drainage follows the "2-4-6 Rule" - medial drainage in 2-4 hours to submandibular nodes, lateral drainage in 1-3 hours to preauricular nodes, and superior drainage in 4-6 hours to deep cervical chains.

Connect this vascular foundation through neural control mechanisms to understand how conjunctival diseases create characteristic symptom patterns and pain responses.

🌊 Vascular Networks: The Conjunctival Circulation Command

🎯 Pattern Recognition: The Diagnostic Decision Matrix

The DISCHARGE-ITCH-PAIN Diagnostic Framework

Systematic conjunctival assessment follows three primary symptom axes that reliably differentiate disease categories:

  • Discharge Characteristics (Pathognomonic Patterns)

    • Purulent/Mucopurulent: Bacterial etiology (85-90% specificity)
      • >5mL daily discharge volume
      • Yellow-green coloration
      • Morning lid crusting
    • Watery/Serous: Viral or allergic (70-80% sensitivity)
      • Clear to slightly cloudy
      • <2mL daily volume
      • No significant crusting
    • Stringy/Mucoid: Allergic or dry eye (90% specificity)
      • Ropy, elastic consistency
      • Associated with itching
      • Worse in dry environments
  • Itch Intensity Scale (Diagnostic Discriminator)

    • Severe Itch (8-10/10): Allergic conjunctivitis (95% specificity)
    • Moderate Itch (4-7/10): Mixed etiology, requires additional features
    • Minimal/No Itch (0-3/10): Bacterial or viral (80% sensitivity)
  • Pain vs. Discomfort (Depth Assessment)

    • True Pain: Suggests deeper involvement (scleritis, keratitis)
    • Foreign Body Sensation: Typical conjunctival inflammation
    • Burning: Often allergic or toxic etiology

📌 Remember: WASP Discharge Patterns - Watery (viral/allergic), Abundant purulent (bacterial), Stringy mucoid (allergic), Painful (deeper pathology)

Injection Pattern Analysis: The Vascular Signature

Conjunctival vascular response patterns provide immediate diagnostic clues that differentiate superficial from deep pathology:

Loading diagram…
Injection TypeVessel MobilityVasoconstrictor ResponseAssociated SymptomsUrgency Level
Superficial DiffuseMobileComplete blanchingDischarge, itchRoutine
CircumlimbalFixedNo responsePain, photophobiaUrgent
Sectoral DeepFixedPartial responseLocalized tenderness24-48 hours
Violaceous DeepFixedNo responseSevere painImmediate
Mixed PatternVariablePartial responseMultiple symptomsSame day

The injection pattern assessment requires systematic evaluation under adequate illumination, comparing treated vs. untreated areas to assess vasoconstrictor response accurately.

💡 Master This: The "Mobile vs. Fixed Rule" - superficial conjunctival vessels move with gentle pressure and blanch completely with vasoconstrictors, while deep vessels remain fixed and show minimal vasoconstrictor response, indicating more serious pathology requiring urgent evaluation.

Connect these pattern recognition skills through morphological assessment to understand how tissue changes reveal specific disease processes and guide targeted therapy.

🎯 Pattern Recognition: The Diagnostic Decision Matrix

🔬 Morphological Signatures: The Tissue Architecture Analysis

Follicular vs. Papillary Response: The Immune Architecture

The conjunctival immune response creates two distinct morphological patterns that reliably indicate underlying pathophysiology:

  • Follicular Response (Lymphoid Aggregation)

    • 1-3mm diameter lymphoid collections
    • Pale centers with peripheral vascularization
    • Predominant in inferior fornix and lower palpebral conjunctiva
      • Viral conjunctivitis: >10 follicles typically present
      • Chlamydial infection: Large follicles (>2mm) in superior fornix
      • Toxic folliculosis: Uniform size distribution
    • Pathognomonic for viral etiology when >15 follicles present
  • Papillary Response (Vascular Proliferation)

    • 0.5-2mm diameter vascular projections
    • Central vascular core with epithelial covering
    • Upper palpebral conjunctiva predominance
      • Allergic conjunctivitis: Small papillae (<1mm)
      • Vernal keratoconjunctivitis: Giant papillae (>1mm)
      • Contact lens-induced: Mixed size distribution
    • >5mm giant papillae indicate severe allergic disease

📌 Remember: FOLLICLES vs. PAPILLAE - Fornix location (follicles), Old viral infections, Lymphoid centers, Lower lid preference vs. Palpebral upper location (papillae), Allergic etiology, Peripheral vessels, Inflammatory response, Large in VKC, Lens-related, Acute allergic, Epithelial covering

Membrane and Pseudomembrane Formation: The Severity Indicators

Conjunctival membrane formation represents severe inflammatory responses that require immediate recognition and aggressive management:

Membrane TypeAdherenceRemoval EffectBleeding RiskAssociated ConditionsPrognosis
True MembraneFirmly adherentBleeding with removalHigh riskDiphtheria, severe bacterialScarring likely
PseudomembraneLoosely adherentNo bleedingMinimal riskSevere viral, SJSVariable scarring
Fibrinous ExudateNon-adherentEasy removalNo bleedingAcute bacterialNo scarring
Cicatricial BandTissue fusionCannot removeTissue damageChronic inflammationPermanent
Loading diagram…

The membrane assessment requires gentle probing with a cotton-tipped applicator to determine adherence without causing unnecessary trauma or bleeding.

💡 Master This: The "Bleeding Rule" for membrane assessment - if gentle removal causes bleeding, treat as true membrane with high scarring risk requiring systemic therapy; if no bleeding occurs, manage as pseudomembrane with moderate risk and close monitoring.

Connect this morphological understanding through treatment algorithms to understand how early recognition of tissue changes guides therapeutic interventions and prevents complications.

🔬 Morphological Signatures: The Tissue Architecture Analysis

⚡ Treatment Algorithms: The Therapeutic Decision Engine

Bacterial Conjunctivitis: The Antimicrobial Strategy

Bacterial conjunctivitis treatment follows evidence-based protocols that achieve cure rates >90% when appropriately selected:

Loading diagram…
  • First-Line Topical Therapy (Mild-Moderate Cases)

    • Moxifloxacin 0.5%: 1 drop TID for 7 days
      • 95% cure rate for common pathogens
      • Excellent Staphylococcus and Streptococcus coverage
      • $45-60 per bottle cost
    • Trimethoprim-Polymyxin B: 1 drop QID for 7-10 days
      • 85-90% cure rate
      • Cost-effective option ($15-25 per bottle)
      • Avoid in sulfa allergy
  • Severe/Hyperacute Management (Gonococcal Suspected)

    • Ceftriaxone 1g IM single dose PLUS topical therapy
    • Hourly topical antibiotics for first 24 hours
    • Saline irrigation every 2-4 hours
    • Partner treatment and STI screening mandatory

📌 Remember: FAST Bacterial Treatment - Fluoroquinolones first-line, Assess severity, Systemic for severe, Treat partners in hyperacute

Allergic Conjunctivitis: The Anti-Inflammatory Cascade

Allergic conjunctivitis management targets multiple inflammatory pathways with symptom relief typically achieved within 15-30 minutes for acute therapy:

Medication ClassOnset TimeDurationEfficacy RateCost RangeBest Use
Antihistamines5-15 minutes4-6 hours80-85%$20-35Acute relief
Mast Cell Stabilizers1-2 weeks12+ hours90-95%$40-60Prevention
Dual-Action Agents15-30 minutes8-12 hours85-90%$50-80First-line
Topical Steroids2-4 hours6-8 hours95-98%$30-50Severe cases
Oral Antihistamines30-60 minutes24 hours70-80%$10-20Systemic symptoms

The allergic conjunctivitis treatment algorithm prioritizes rapid symptom control while establishing long-term management for chronic cases.

💡 Master This: The "15-Minute Rule" - if topical antihistamines don't provide significant relief within 15-30 minutes, consider alternative diagnosis or add topical steroid for 3-5 days with close monitoring.

Viral Conjunctivitis: The Supportive Care Protocol

Viral conjunctivitis management focuses on symptom relief and complication prevention since >95% of cases resolve spontaneously within 7-14 days:

  • Supportive Therapy (Evidence-Based Comfort)

    • Preservative-free artificial tears: Every 2-4 hours
    • Cold compresses: 10-15 minutes QID
    • Topical antihistamines: For associated itching
      • Ketotifen 0.025%: BID for comfort
      • Avoid topical steroids unless keratitis present
  • Complication Prevention (High-Risk Cases)

    • Epidemic keratoconjunctivitis with keratitis
    • Low-dose topical steroids: Prednisolone 0.12% BID
    • Monitor IOP weekly during steroid use
    • Taper over 2-3 weeks to prevent rebound

📌 Remember: CARE for Viral - Cold compresses, Artificial tears, Rest and hygiene, Evaluate for complications

Connect this therapeutic foundation through advanced management strategies to understand how complex cases require multimodal approaches and specialist intervention.

⚡ Treatment Algorithms: The Therapeutic Decision Engine

🧬 Advanced Integration: The Systemic-Ocular Interface

Autoimmune Disease Signatures: The Systemic Warning System

The conjunctiva serves as an accessible window for systemic autoimmune disease monitoring, with specific patterns predicting disease activity and treatment response:

  • Sjögren's Syndrome (Glandular Destruction Pattern)

    • Goblet cell density <150/mm² (normal >400/mm²)
    • Rose Bengal staining score >4/9 indicates severe disease
    • Schirmer test <5mm at 5 minutes
      • Correlates with salivary gland dysfunction (r=0.78)
      • Anti-SSA/SSB antibodies present in 85% of cases
      • Lymphoma risk increases 44-fold with severe disease
  • Ocular Cicatricial Pemphigoid (Progressive Scarring)

    • Fornix shortening >2mm indicates active disease
    • Symblepharon formation progresses 1-2mm/month untreated
    • Basement membrane antibodies (BP180, BP230)
      • Direct immunofluorescence positive in >90%
      • Systemic involvement in 60-70% of cases
      • 5-year blindness risk 25-30% without treatment

📌 Remember: SIGHT Autoimmune Markers - Sjögren's (goblet loss), Immunofluorescence (OCP), Glandular dysfunction, High lymphoma risk, Tissue scarring progression

Metabolic Disease Manifestations: The Biochemical Fingerprints

Conjunctival examination reveals specific metabolic abnormalities that guide systemic diagnosis and monitoring:

Loading diagram…
Metabolic ConditionConjunctival FindingPrevalenceDiagnostic ValueSystemic Correlation
CystinosisCystine crystals100% by age 2PathognomonicGFR <60 in 90%
Wilson DiseaseCopper deposition65-80%Highly specificLiver dysfunction >85%
HypercalcemiaCalcium deposits40-60%Moderately specificPTH elevation >75%
GoutUric acid crystals15-25%Low sensitivityJoint involvement >90%
AmyloidosisAmyloid deposits30-45%Tissue confirmationCardiac involvement >60%

The metabolic assessment requires slit-lamp examination with high magnification to identify characteristic crystal patterns and deposits.

💡 Master This: The "Crystal Clock" - cystine crystals appear earliest (infancy), copper deposits develop gradually (adolescence-adulthood), and calcium deposits occur acutely with metabolic derangement, providing temporal clues for systemic disease progression.

Vascular Disease Indicators: The Microcirculation Mirror

Conjunctival vascular changes reflect systemic cardiovascular health and predict disease progression:

  • Diabetic Microangiopathy (Early Detection System)

    • Microaneurysms visible before retinal changes in 35% of cases
    • Capillary dropout correlates with HbA1c >8.5%
    • Vessel tortuosity increases with disease duration >10 years
      • Basement membrane thickening measurable by OCT
      • Perfusion defects predict retinopathy progression
      • Inflammatory markers elevated in conjunctival vessels
  • Hypertensive Changes (Pressure Response Patterns)

    • Arteriovenous nicking visible in severe hypertension
    • Vessel caliber changes correlate with systolic BP >160mmHg
    • Hemorrhages indicate malignant hypertension
      • Recovery time 2-4 weeks with BP control
      • Persistent changes suggest end-organ damage

📌 Remember: VESSEL Assessment - Vascular tortuosity, Early diabetic changes, Systemic correlation, Severe hypertension signs, End-organ damage, Longitudinal monitoring

Connect this advanced understanding through clinical mastery tools to develop systematic approaches for complex conjunctival disease management and systemic disease recognition.

🧬 Advanced Integration: The Systemic-Ocular Interface

🎯 Clinical Mastery Arsenal: The Diagnostic Command Center

The 5-Minute Diagnostic Protocol: Systematic Excellence

Master clinicians follow a standardized assessment sequence that captures >98% of clinically significant findings:

  • Visual Inspection (30 seconds)

    • Discharge character: Purulent vs. watery vs. stringy
    • Injection pattern: Superficial vs. deep vs. mixed
    • Lid involvement: Swelling, crusting, malposition
      • Bilateral vs. unilateral presentation
      • Severity grading (mild/moderate/severe)
      • Associated skin changes
  • Biomicroscopic Examination (2-3 minutes)

    • Follicle count and distribution: >10 suggests viral
    • Papillae size and location: >1mm indicates severe allergy
    • Membrane assessment: True vs. pseudo vs. fibrinous
      • Vessel mobility testing with gentle pressure
      • Vasoconstrictor response (phenylephrine 10%)
      • Fornix depth measurement and scarring assessment
  • Diagnostic Testing (1-2 minutes)

    • Gram stain for hyperacute cases
    • Culture when treatment failure occurs
    • Rapid antigen tests for specific pathogens

📌 Remember: RAPID Assessment - Red eye pattern, Assess discharge, Palpate nodes, Inspect closely, Determine etiology

Essential Clinical Thresholds: The Decision Points

Critical numerical thresholds that guide immediate clinical decisions:

Clinical ParameterNormal RangeMild DiseaseModerate DiseaseSevere DiseaseAction Required
Follicle Count0-56-1011-20>20Viral workup
Papillae Size<0.5mm0.5-1mm1-3mm>3mmAllergy specialist
Discharge Volume<1mL/day1-3mL3-8mL>8mLCulture required
Fornix Depth8-10mm6-8mm4-6mm<4mmCicatricial workup
IOP Elevation<21mmHg21-25mmHg25-30mmHg>30mmHgStop steroids
Loading diagram…

Treatment Response Monitoring: The Outcome Predictors

Systematic follow-up protocols ensure optimal outcomes and early complication detection:

  • 48-Hour Assessment (Bacterial Cases)

    • >50% symptom improvement expected
    • Discharge reduction >75% indicates appropriate therapy
    • No improvement requires culture and sensitivity
      • Resistance patterns guide second-line therapy
      • Systemic involvement consideration
      • Alternative diagnosis evaluation
  • 1-Week Evaluation (All Cases)

    • Complete resolution expected in >90% of cases
    • Persistent symptoms require specialist referral
    • Complication screening (scarring, dry eye, IOP elevation)

💡 Master This: The "48-Hour Rule" - bacterial conjunctivitis should show significant improvement within 48 hours of appropriate antibiotic therapy; failure to improve indicates resistance, alternative diagnosis, or complications requiring immediate reassessment.

📌 Remember: FOLLOW Protocol - Forty-eight hour check, Outcome assessment, Look for complications, Long-term monitoring, Optimize therapy, Watch for recurrence

This clinical mastery framework provides the systematic approach needed to excel in conjunctival disease management, ensuring consistent diagnostic accuracy and optimal patient outcomes across all disease categories.

🎯 Clinical Mastery Arsenal: The Diagnostic Command Center

Unlock the full lesson and continue reading

Signup to continue reading this lesson and unlimited access questions, flashcards, AI notes, and more

Scan to download app

Scan to download
UNLOCK FREE ACCESS

Practice Questions: Diseases of the Conjunctiva

  1. 1. Epidemic relapsing fever is caused by which of the following spirochetes?

    • A. Borrelia recurrentis (Africa)
    • B. Borrelia parkeri (North America)
    • C. Borrelia hermsii (North America)
    • D. Borrelia duttonii (East Africa)
    Show answer

    Answer: A. Borrelia recurrentis (Africa)

    Borrelia recurrentis (Africa) is correct because it causes epidemic relapsing fever transmitted by the human body louse. Borrelia parkeri (North America) causes tick-borne endemic relapsing fever rather than the epidemic louse-borne form. Borrelia hermsii (North America) also causes tick-borne endemic relapsing fever. Borrelia duttonii (East Africa) causes tick-borne endemic relapsing fever and therefore does not answer the epidemic-relapsing-fever question.

  2. 2. Which listed cause typically produces superficial corneal vascularization through chronic hypoxia?

    • A. Chemical corneal burn
    • B. Interstitial keratitis
    • C. Corneal graft rejection
    • D. Contact lens wear
    Show answer

    Answer: D. Contact lens wear

    Contact lens wear - Inappropriate contact lens wear, especially extended wear or poor hygiene, can cause superficial corneal vascularization. - The lens causes chronic hypoxia or inflammation, stimulating vessel growth into the normally avascular cornea. Chemical corneal burn - Chemical burns can cause severe corneal injury followed by vascularization as part of the healing response. - This reflects tissue injury and inflammation rather than chronic contact lens-related hypoxia. Interstitial keratitis - Interstitial keratitis causes stromal inflammation that may produce ghost vessels or active corneal vascularization. - It involves stromal inflammation rather than chronic hypoxia and is commonly associated with infections such as syphilis or Lyme disease. Corneal graft rejection - Corneal graft rejection may produce neovascularization through a severe immune response affecting graft survival. - This is immune-mediated rather than a consequence of chronic hypoxia.

  3. 3. Which statement about the disorder shown is NOT correct?

    • A. Classified using NOSPECS
    • B. Prevalence above 10% in Graves disease
    • C. May cause visual loss
    • D. Parallels biochemical thyroid control
    Show answer

    Answer: D. Parallels biochemical thyroid control

    Parallels biochemical thyroid control - This statement is false because thyroid-associated ophthalmopathy (TAO) does not reliably improve in parallel with biochemical thyroid control; its autoimmune orbital process may progress independently. - Although controlling hyperthyroidism is important for overall health, it often has limited effect on established orbital inflammation and structural changes affecting the eyes. Classified using NOSPECS - The NOSPECS classification is used to grade the severity of thyroid-associated ophthalmopathy, covering features from absent signs through sight loss. - It primarily records clinical signs and symptoms; disease activity, particularly during acute inflammation, is better assessed with the Clinical Activity Score (CAS). Prevalence above 10% in Graves disease - Thyroid-associated ophthalmopathy is relatively common in Graves’ disease, affecting approximately 25–50% when even mild ophthalmic involvement is included. - A clinically significant degree occurs less often, but the broad prevalence supports the statement that any degree of ophthalmopathy occurs in more than 10% of affected patients. May cause visual loss - Severe thyroid-associated ophthalmopathy can cause compressive optic neuropathy from enlarged extraocular muscles, producing potentially irreversible visual loss. - Marked proptosis and lid retraction may cause exposure keratopathy, ulceration, and secondary visual impairment, further supporting this statement.

  4. 4. Which of the following is NOT a feature of CREST syndrome?

    • A. Malar erythema
    • B. Sclerodactyly
    • C. Raynaud phenomenon
    • D. Calcinosis cutis
    Show answer

    Answer: A. Malar erythema

    Malar erythema - Malar erythema is the characteristic butterfly rash of systemic lupus erythematosus, not limited cutaneous systemic sclerosis. - CREST skin involvement typically affects the face and distal extremities and includes sclerodactyly, calcinosis, and telangiectasia rather than a malar rash. Sclerodactyly - Sclerodactyly is the thickening and tightening of the skin of the fingers, producing a characteristic feature of systemic sclerosis. - It is represented by the S in the CREST acronym and therefore supports, rather than excludes, the diagnosis. Raynaud phenomenon - Raynaud phenomenon is episodic digital vasospasm triggered by cold or stress and is commonly an early manifestation of CREST syndrome. - It forms the R in the CREST acronym, making it a characteristic associated feature rather than the exception. Calcinosis cutis - Calcinosis cutis, or soft tissue calcification, may present as painful nodules around the fingertips or pressure points. - Calcinosis is the C in CREST and is therefore a recognized feature of limited cutaneous systemic sclerosis, not the incorrect option.

  5. 5. All of the following are bacterial causes of neonatal conjunctivitis (ophthalmia neonatorum), EXCEPT:

    • A. Neisseria gonorrhoeae
    • B. Chlamydia trachomatis
    • C. Pseudomonas aeruginosa
    • D. Aspergillus fumigatus
    Show answer

    Answer: D. Aspergillus fumigatus

    Aspergillus fumigatus Aspergillus is the least likely organism listed: fungal neonatal conjunctivitis is exceptionally uncommon, whereas Gonococcus, Chlamydia, and Pseudomonas are established bacterial causes; rarity does not mean fungal infection is impossible. Neisseria gonorrhoeae - Neisseria gonorrhoeae is a recognized cause of ophthalmia neonatorum, usually producing severe purulent discharge within the first 2–5 days of life. - Untreated gonococcal conjunctivitis may rapidly cause corneal ulceration and blindness, making it an important neonatal ocular infection. Chlamydia trachomatis - Chlamydia trachomatis is a common cause of neonatal conjunctivitis, typically presenting 5–14 days after birth with mucopurulent discharge. - Neonatal chlamydial infection may also be associated with infant pneumonia, supporting it as a cause rather than the exception. Pseudomonas aeruginosa - Pseudomonas aeruginosa can produce severe, rapidly progressive neonatal conjunctivitis and keratitis, particularly in premature infants or after exposure to contaminated solutions. - Its aggressive course and risk of ocular morbidity make Pseudomonas a recognized, though less typical, cause of neonatal conjunctivitis.

  6. 6. Phlyctenular conjunctivitis is primarily associated with hypersensitivity to which of the following?

    • A. Staphylococcus aureus
    • B. Streptococcus pneumoniae
    • C. Chlamydia trachomatis
    • D. Aspergillus fumigatus
    Show answer

    Answer: A. Staphylococcus aureus

    Staphylococcus aureus - Phlyctenular conjunctivitis is a delayed (Type IV) hypersensitivity reaction to microbial antigens; Staphylococcus aureus is a common trigger, particularly in developed countries, while tubercular hypersensitivity remains an important association in endemic settings. - This reaction produces phlyctenules, small inflammatory nodules on the conjunctiva or cornea; Mycobacterium tuberculosis is another recognized trigger, especially in endemic regions. Streptococcus pneumoniae - Streptococcus pneumoniae commonly causes acute bacterial conjunctivitis with purulent discharge and redness, rather than the delayed hypersensitivity reaction characteristic of phlyctenular conjunctivitis. - Phlyctenular conjunctivitis is primarily linked to hypersensitivity to bacterial antigens, especially Staphylococcus, although other organisms may occasionally act as triggers. Aspergillus fumigatus - Aspergillus is more commonly associated with fungal keratitis or allergic bronchopulmonary disease, particularly in susceptible or immunocompromised individuals. - Fungal conjunctival infections are rare and do not typically produce the phlyctenular nodules caused by delayed hypersensitivity to bacterial antigens. Chlamydia trachomatis - Chlamydia trachomatis typically causes chronic follicular conjunctivitis, including trachoma and adult inclusion conjunctivitis, rather than phlyctenular nodules. - Although chlamydial infection may cause pannus formation, it is not the usual cause of the delayed hypersensitivity reaction associated with phlyctenular conjunctivitis.

  7. 7. A patient with vernal keratoconjunctivitis has persistent vigorous eye rubbing and has never received corticosteroids. Which complication is characteristically associated with the rubbing?

    • A. Retinal detachment
    • B. Keratoconus
    • C. Vitreous hemorrhage
    • D. Cataract
    Show answer

    Answer: B. Keratoconus

    Keratoconus is the complication characteristically associated with chronic vigorous eye rubbing in vernal keratoconjunctivitis. Retinal detachment is not the characteristic rubbing-associated complication tested here. Vitreous hemorrhage is a posterior-segment bleeding disorder and is not the expected consequence of allergic eye rubbing. Cataract is an important complication of corticosteroid exposure, but that exposure is explicitly absent and cataract does not explain the rubbing-associated corneal change.

  8. 8. Which of the following is true about Bitot's spots?

    • A. Seen with fat malabsorption
    • B. Most common on the nasal conjunctiva
    • C. Predispose to pterygium formation
    • D. Caused by hyperplasia of goblet cells
    Show answer

    Answer: A. Seen with fat malabsorption

    Seen with fat malabsorption - This is correct because vitamin A is fat-soluble and requires dietary fat and bile salts for absorption; fat malabsorption can therefore cause deficiency and Bitot’s spots. - Conditions such as celiac disease, chronic pancreatitis, and biliary obstruction may produce secondary vitamin A deficiency, leading to xerophthalmia and Bitot’s spots. Caused by hyperplasia of goblet cells - Bitot’s spots result from vitamin A deficiency, causing conjunctival epithelial keratinization and squamous metaplasia rather than goblet-cell hyperplasia. - Vitamin A deficiency is associated with loss or destruction of goblet cells, contributing to conjunctival xerosis and the characteristic foamy, keratin-containing appearance. Most common on the nasal conjunctiva - The usual site is the temporal interpalpebral conjunctiva, not the nasal side; temporal lesions are typically more characteristic and may appear first. - Although Bitot’s spots can occur nasally, the temporal location is the distinguishing common site, so this statement is not the best description. Predispose to pterygium formation - Bitot’s spots do not predispose to pterygium; they are manifestations of vitamin A deficiency and conjunctival keratinization. - Pterygium is associated mainly with chronic ultraviolet exposure and elastotic degeneration, rather than with Bitot’s spots or vitamin A deficiency.

  9. 9. Epithelial xerosis of the conjunctiva is characteristically seen in which condition?

    • A. Xerophthalmia
    • B. Diphtheritic conjunctivitis
    • C. Trachoma
    • D. Ocular cicatricial pemphigoid
    Show answer

    Answer: A. Xerophthalmia

    Xerophthalmia Xerophthalmia is the spectrum of ocular manifestations of vitamin A deficiency. Conjunctival epithelial xerosis is one manifestation: goblet cell loss and squamous metaplasia produce conjunctival dryness and epithelial thickening. Diphtheritic conjunctivitis - Diphtheritic conjunctivitis causes acute severe inflammation with an adherent true conjunctival membrane that may bleed on removal, rather than epithelial xerosis. - Its primary features include bacterial infection and possible systemic illness; conjunctival dryness from vitamin A deficiency is the distinguishing cause of epithelial xerosis. Trachoma - Chlamydia trachomatis causes chronic trachoma, with inflammation, scarring, and possible blindness, rather than primary epithelial xerosis. - Advanced scarring may cause secondary dryness through symblepharon or entropion, but this is distinct from the epithelial changes of xerophthalmia. Ocular cicatricial pemphigoid - Autoimmune blistering conjunctivitis causes immune-mediated subepithelial blistering, conjunctival scarring, and shrinkage, not primary epithelial xerosis. - Although it can produce severe ocular surface damage and visual loss, its distinguishing mechanism is autoimmune scarring rather than vitamin A deficiency.

  10. 10. In a patient with acute anterior uveitis presenting with raised intraocular pressure, the PRIMARY treatment should be:

    • A. Topical steroids
    • B. Topical beta-blockers
    • C. Cycloplegics
    • D. Miotics
    Show answer

    Answer: A. Topical steroids

    Topical steroids - Topical corticosteroids are the primary treatment for acute anterior uveitis, suppressing intraocular inflammation that causes tissue damage and may contribute to raised intraocular pressure. - Controlling inflammation is essential because trabecular meshwork dysfunction and synechiae can produce secondary IOP elevation; pressure-lowering therapy may be added when required. Topical beta-blockers - Topical beta-blockers lower intraocular pressure but do not suppress the inflammatory process responsible for acute anterior uveitis. - They may be used as an adjunct for raised pressure, but are not the primary treatment because untreated inflammation can continue causing ocular damage. Cycloplegics - Cycloplegics relieve pain caused by ciliary spasm and help prevent posterior synechiae by maintaining pupillary dilation. - They are useful adjuncts in anterior uveitis but do not directly treat inflammation or primarily control the raised intraocular pressure. Miotics - Miotics constrict the pupil and can increase ciliary spasm, worsening pain in acute anterior uveitis. - They may promote posterior synechiae and do not treat the underlying inflammation or raised intraocular pressure, so they are contraindicated.

Flashcards: Diseases of the Conjunctiva

  1. 1. Inclusion conjunctivitis is caused by .

    Show answer

    Chlamydia trachomatis serotypes D K

  2. 2. Papillary hyperplasia is a sign of trachoma

    Show answer

    conjunctival

  3. 3. Mucus fishing syndrome is closely related to  conjunctivitis.

    Show answer

    giant papillary

  4. 4. conjunctivitis is also called as spring catarrh or warm weather conjunctivitis

    Show answer

    Vernal

  5. 5. Arlt's line is a sign of trachoma

    Show answer

    conjunctival

  6. 6. Redness and photophobia with the following characteristic lesion is suggestive of _____ conjunctivitis

    Show answer

    Phlyctenular

  7. 7. The given image is of _____ of the eye

    Show answer

    symblepharon

  8. 8. Only _____ reaction is seen in VKC; no _____ reaction

    Show answer

    papillary · follicular

  9. 9. The two most common causes of bacterial conjunctivitis are _____ and _____.

    Show answer

    Staphylococcus aureus · Streptococcus pneumoniae

  10. 10. Pinguecula is located _____, and is more common on the _____ side

    Show answer

    bilaterally · nasal

Everything you need for Indian Medical PG prep

Get full Oncourse access with lessons, practice questions, flashcards and AI study tools.

GET STARTED FOR FREE
75% OFFLimited time offer
GET 75% OFF